HERON THERAPEUTICS, INC. /DE/ (HRTX) has 8 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 10, 2026 filed Aug. 6, 2026 | Hensley Mark Earl Chief Operating Officer | — | +22,362 | +7% | No | |
|
|
||||||
| Aug. 3, 2026 filed July 31, 2026 | Hensley Mark Earl Chief Operating Officer | $0 | 23,538 | +8% | No | |
|
|
||||||
| Aug. 3, 2026 filed July 30, 2026 | Forbes William P EVP, Chief Development Officer | — | +16,789 | +17% | No | |
|
|
||||||
| Aug. 3, 2026 filed July 30, 2026 | Duarte Ira EVP, Chief Financial Officer | — | +18,053 | +18% | No | |
|
|
||||||
| Aug. 3, 2026 filed July 30, 2026 | Collard Craig A Chief Executive Officer | $0 | 169,620 | +32% | No | |
|
|
||||||
Showing the 5 most recent of 8 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free